The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count

Abstract Programmed cell death ligand‐1 (PD‐L1) is a ligand for programmed cell death‐1 (PD‐1) that negatively regulates T‐cell activation and plays a crucial role in suppressing anti‐tumor host immunity. Although PD‐L1 is a promising immunotherapy target in various cancers, including urothelial car...

Full description

Bibliographic Details
Main Authors: Yu Miyama, Teppei Morikawa, Jimpei Miyakawa, Yuichi Koyama, Taketo Kawai, Haruki Kume, Masashi Fukayama
Format: Article
Language:English
Published: Wiley 2018-09-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1686